REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens.
- DOI
- 10.1093/oncolo/oyaf135
- Published
- 2025 Jun 4
- Container
- The oncologist
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyaf135,
title = {REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens.},
author = {Zhong J and Jang A and Abuqayas B and Basu A and Benjamin DJ and Bhatlapenumarthi V and Bilen MA and Buch D and Chang M and Chin E and Darabi S and Dhanikonda N and Ghatalia P and Grigg CM and Grier AL and Jindal T and Jung J and Kilari D and Kumar HLS and Lee S and Neelands B and Pandya C and Pawalek J and Staggers J and Yildirim A and Zakharia Y and Zarrabi KK and Zimmerman M and Sledge G and Spetzler D and Elliott A and McKay RR and Barata PC},
year = {2025},
journal = {The oncologist},
doi = {10.1093/oncolo/oyaf135},
url = {https://doi.org/10.1093/oncolo/oyaf135}
}RIS
TY - JOUR TI - REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens. AU - Zhong J AU - Jang A AU - Abuqayas B AU - Basu A AU - Benjamin DJ AU - Bhatlapenumarthi V AU - Bilen MA AU - Buch D AU - Chang M AU - Chin E AU - Darabi S AU - Dhanikonda N AU - Ghatalia P AU - Grigg CM AU - Grier AL AU - Jindal T AU - Jung J AU - Kilari D AU - Kumar HLS AU - Lee S AU - Neelands B AU - Pandya C AU - Pawalek J AU - Staggers J AU - Yildirim A AU - Zakharia Y AU - Zarrabi KK AU - Zimmerman M AU - Sledge G AU - Spetzler D AU - Elliott A AU - McKay RR AU - Barata PC PY - 2025 JO - The oncologist DO - 10.1093/oncolo/oyaf135 UR - https://doi.org/10.1093/oncolo/oyaf135 ER -
APA
J, Z., A, J., B, A., A, B., DJ, B., V, B., MA, B., D, B., M, C., E, C., S, D., N, D., P, G., CM, G., AL, G., T, J., J, J., D, K., HLS, K., S, L., B, N., C, P., J, P., J, S., A, Y., Y, Z., KK, Z., M, Z., G, S., D, S., A, E., RR, M., & PC, B. (2025). REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens.. The oncologist. https://doi.org/10.1093/oncolo/oyaf135
Source records
- pubmed · retrieved 2026-09-26T20:57:06.216Z
- europe-pmc · retrieved 2026-09-26T20:57:06.226Z